MGC Pharmaceuticals signs supply deal with AMC for phytomedicine products

MGC Pharmaceuticals, a developer of phytocannabinoid-derived medicines, has signed a $24 million supply and distribution deal with US-based AMC Holdings. The deal is for the ... Read More